Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Myeloma 2021'

Myeloma 2021 published presentations and documents on DocSlides.

meeting summary Autumn 2021 MEETINGS in Multiple Myeloma

meeting summary Autumn 2021 MEETINGS in Multiple Myeloma

  • cadie
  • 23 Slides

IMW | SOHO | SOHO Italy. Dr.. Claudio . Cerchione...

Smouldering myeloma

Smouldering myeloma

  • faustina-dinatale
  • 3 Slides

What is smouldering myeloma? Smouldering myeloma (...

Genomic Sequencing in Myeloma:

Genomic Sequencing in Myeloma:

  • lindy-dunigan
  • 34 Slides

Ready for Prime Time?. DANA-FARBER . CANCER INSTI...

How to Manage High Risk Myeloma

How to Manage High Risk Myeloma

  • tatiana-dople
  • 62 Slides

Dr Matthew Jenner. Consultant Haematologist. Sout...

The place of newer imaging techniques in multiple myeloma

The place of newer imaging techniques in multiple myeloma

  • alexa-scheidler
  • 38 Slides

Dr. Andrew Chantry. Senior Clinical Lecturer and...

Immunotherapy in Multiple Myeloma: where do we go ?

Immunotherapy in Multiple Myeloma: where do we go ?

  • kittie-lecroy
  • 101 Slides

Paul Moss. Birmingham, UK. Outline. Introduction ...

Multiple Myeloma

Multiple Myeloma

  • aaron
  • 48 Slides

NICE Guideline. Published Feb 2016. Adults with m...

Myeloma hope

Myeloma hope

  • sherrill-nordquist
  • 17 Slides

new treatment in the horizon. Dr Amin . I. slam ....

Biomarkers for personalized therapy in myeloma

Biomarkers for personalized therapy in myeloma

  • tawny-fly
  • 27 Slides

Mike Chapman. University of Cambridge Department ...

Nurses' Toolbox: How to Improve Patient Outcomes in Multiple Myeloma

Nurses' Toolbox: How to Improve Patient Outcomes in Multiple Myeloma

  • lindy-dunigan
  • 0 Slides

Program Goals. Defining Multiple Myeloma. Case 1....

Mait Raava Estonian Myeloma Society

Mait Raava Estonian Myeloma Society

  • tawny-fly
  • 0 Slides

Copenhagen. , . June 11. th. . 2016. EU Drug App...

Smoldering Myeloma: To Treat or not to Treat Ruben Niesvizky MD

Smoldering Myeloma: To Treat or not to Treat Ruben Niesvizky MD

  • alida-meadow
  • 33 Slides

Smoldering Myeloma: To Treat or not to Treat Rube...

Multiple Myeloma: Is it now a curable disease?

Multiple Myeloma: Is it now a curable disease?

  • scoopulachanel
  • 26 Slides

Pritesh Patel, MD. OVErview. Disease overview. How...

Hematology Mastery in Multiple Myeloma

Hematology Mastery in Multiple Myeloma

  • frostedikea
  • 24 Slides

Part I: Smoldering Multiple Myeloma . and . Induct...

multiple myeloma: D-type

multiple myeloma: D-type

  • megan
  • 41 Slides

cyclin. and PI3k pathways. UKMF Spring meeting 20...

Plasma cell Disorders From MGUS to multiple myeloma

Plasma cell Disorders From MGUS to multiple myeloma

  • susan2
  • 17 Slides

Vi Dao, MD, FRCPC. vdao@cancercare.mb.ca. Presente...

Myeloma: Symptoms to diagnosis

Myeloma: Symptoms to diagnosis

  • samantha
  • 8 Slides

Can we do better?. [Hospital name]. [Date]. What i...

IMAGING OF MEDULLARY COMPLICATIONS OF MYELOMA

IMAGING OF MEDULLARY COMPLICATIONS OF MYELOMA

  • WatercolorWanderlust
  • 13 Slides

H . Nèji. , H . Abid. , A . Mâalej. , S . Haddar...

The use of oncolytic virus therapy for myeloma shows considerable promise in pre-clinical models

The use of oncolytic virus therapy for myeloma shows considerable promise in pre-clinical models

  • Thunderbolt
  • 18 Slides

Miss Georgia Stewart . Sheffield Myeloma Research ...

Multiple myeloma: What’s new?

Multiple myeloma: What’s new?

  • sadie
  • 91 Slides

Grace B. Athas, Ph.D. . MLS. Department of patholo...

Myeloma is the cancer with the longest pathway to diagnosis in the UK

Myeloma is the cancer with the longest pathway to diagnosis in the UK

  • eliza
  • 1 Slides

[Hospital]. [date]. Myeloma: Symptoms to diagnosis...

MRD in myeloma

MRD in myeloma

  • mitsue-stanley
  • 36 Slides

UKMF Spring Day. Assessment of disease response, ...

The Biology of Relapsed and Refractory Multiple Myeloma

The Biology of Relapsed and Refractory Multiple Myeloma

  • alexa-scheidler
  • 42 Slides

Topics. Current Treatment Options for Relapsed/Re...

Practical Oncology

Practical Oncology

  • luanne-stotts
  • 42 Slides

Round Cell Tumors. Wendy Blount, DVM. Round Cell ...

Relapsed and Refractory Myeloma

Relapsed and Refractory Myeloma

  • jane-oiler
  • 85 Slides

Ruben Niesvizky. Myeloma Center. Myelomacenter.or...

2012 Student Research

2012 Student Research

  • luanne-stotts
  • 14 Slides

Our Dana-Farber Experience. Deirdre Foley & M...

Scottsdale, Arizona

Scottsdale, Arizona

  • jane-oiler
  • 36 Slides

Rochester, Minnesota. Jacksonville, Florida. Mult...

Dr Denis O’Keeffe

Dr Denis O’Keeffe

  • trish-goza
  • 37 Slides

Multiple myeloma .The management of the newly dia...

Healthcare Global Enterprises Ltd

Healthcare Global Enterprises Ltd

  • yoshiko-marsland
  • 38 Slides

Study of . clinocopathological. profile and chr...

Hans Scheurer President

Hans Scheurer President

  • ellena-manuel
  • 0 Slides

. Myeloma. Patients Europe. Disclosure. I have ...

Starr Morning Report Austin Akers, MD Internal Medicine PGY-3

Starr Morning Report Austin Akers, MD Internal Medicine PGY-3

  • test
  • 23 Slides

Starr Morning Report Austin Akers, MD Internal Me...

Antibodies, BiTEs , and CARs: the new ABC’s of Myeloma Therapy

Antibodies, BiTEs , and CARs: the new ABC’s of Myeloma Therapy

  • aaron
  • 35 Slides

June 6, 2019. Adam D. Cohen, MD. Director, Myelom...

Protein dynamics in early disease

Protein dynamics in early disease

  • oneill
  • 19 Slides

Professor Mark Drayson, University of Birmingham. ...

Laboratory testing of monoclonal gammopathy

Laboratory testing of monoclonal gammopathy

  • PeacefulPassion
  • 23 Slides

What tests to order and how to interpret them. Pre...

Lab Results: What are they and why do we care?

Lab Results: What are they and why do we care?

  • LoudAndProud
  • 45 Slides

Colleen H. Erb, MSN, CRNP ACNP-BC, AOCNP. Hematolo...

Subhead Multiple myeloma (MM) is characterized by significant genetic diversity at subclonal levels

Subhead Multiple myeloma (MM) is characterized by significant genetic diversity at subclonal levels

  • KissesForYou
  • 1 Slides

Although . genome profiling studies have demonstra...

Central diabetes insipidus

Central diabetes insipidus

  • Younggunner
  • 42 Slides

Maryam-kabootari. MD. Research Institute for Endo...

Considerations for Optimizing Transplant in Multiple Myeloma Patient Management

Considerations for Optimizing Transplant in Multiple Myeloma Patient Management

  • TravelingSoulmate
  • 77 Slides

PARAMESWARAN HARI MD. MEDICAL COLLEGE OF WISCONSIN...

UNDERSTANDING

UNDERSTANDING

  • sophie
  • 25 Slides

MULTIPLE MYELOMA AND LABORATORY VALUES Benjamin...

GILDA146SCLUB

GILDA146SCLUB

  • jordyn
  • 68 Slides

GILDA’SCLUB MULTIPLEMYELOMA facing multiple m...

Copyright © 2024 DocSlides. All Rights Reserved